Phase 1 NTRK Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration

Avistone Biotechnology Co., Ltd.96 enrolled5 locationsNCT06716138

Recruiting

Phase 1Phase 2

A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities

Solid Tumors Harboring NTRK FusionNTRKNTRK Gene Fusion+1 more

Cullgen (Shanghai),Inc42 enrolled6 locationsNCT07394374

Recruiting

Phase 1Phase 2

Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors

Advanced Solid Tumors Harboring NTRK FusionPrimary Central Nervous System Tumors Harboring NTRK Fusion

Beijing InnoCare Pharma Tech Co., Ltd.70 enrolled1 locationNCT05745623